Developer docs
API playgroundTry for free, no card

Search company profiles

Caesarea Medical Electronics

Full company profile

uuid000hgfa

Namestring
Caesarea Medical Electronics
Legal namestring
Caesarea Medical Electronics
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Caesarea Medical Electronics (CME) is a privately held Israeli medical-device company founded in 1993 and headquartered in Caesarea, Israel, that designs, manufactures, and distributes infusion and syringe pumps for healthcare providers globally. Its core product portfolio centers on the BodyGuard family of infusion pumps — including the BodyGuard 323 and BodyGuard 545 multi-functional infusion therapy devices — and the T34 syringe pump, paired with a recurring stream of disposable administration sets that anchor lifetime customer value per installed device. The company operates a direct B2B go-to-market selling hardware and consumables into hospitals, clinics, and medical facilities, and has extended the same underlying platforms into a separate Vet Care channel serving veterinary clinics, providing modest vertical diversification.

CME generates revenue primarily through unit sales of regulated infusion and syringe pump hardware plus the associated disposable administration-set consumables, with supporting product training and clinical-support services that reinforce installed-base retention. The company claims global distribution and maintains an organizational headcount in the 101–250 range, consistent with a mid-sized established manufacturer rather than a growth-stage venture. Its only documented capital event in the available data is a $100M funding round led by CareFusion on 2013-12-09, which signals that a strategic acquirer/distributor once assessed material commercial scale, though no current operating, revenue, or pipeline metrics are disclosed in the input.

Technology-wise, CME is a traditional regulated-hardware medical-device manufacturer rather than a software- or AI-defined business; its website is noted to rely on Adobe Flash, indicating a dated digital footprint. The competitive positioning rests on a three-decade brand in the BodyGuard line, switching costs tied to clinical-workflow integration, and the regulatory barrier inherent in infusion-device clearances, rather than on differentiated intelligence or data capabilities.

Short descriptiontext

Caesarea Medical Electronics is an Israeli medical-device company founded in 1993 that designs and sells infusion pumps, syringe pumps, and disposable administration sets to hospitals, clinics, and veterinary facilities globally under the BodyGuard and T34 brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCaesarea, Israel
HQ citystring
Caesarea
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
infusion pumps, syringe pumps, IV medication delivery, disposable administration sets, medical device manufacturing
Industry2 codes
PRIMARYHLAHAIAF
Infusion Pumps (Ambulatory/Stationary)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAH
Infusion Sets, Catheters & Pump Consumables
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sale of infusion pumps, syringe pumps, and related medical devices along with disposable administration sets to healthcare providers and institutions.

cme-infusion.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Caesarea Medical Electronics designs, develops, and manufactures a range of infusion and syringe pumps for intravenous (IV) medication delivery. The company produces multi-functional infusion therapy devices and a wide range of single-use disposable administration sets used in healthcare settings.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Caesarea Medical Electronics designs and manufactures a comprehensive portfolio of intravenous medication delivery solutions. The core product line consists of infusion pumps and syringe pumps for controlled IV medication administration, complemented by multi-functional infusion therapy devices. The company also produces disposable administration sets as consumable accessories. Specific product models referenced include the BodyGuard 323, BodyGuard 545 infusion pumps, and T34 Syringe Pump. The portfolio targets healthcare providers requiring reliable IV medication delivery and infusion therapy capabilities.

Product and service4 records
1BodyGuard 323
CategoryInfusion Pumps
Description

Infusion pump model in the BodyGuard product line, used for intravenous medication delivery in clinical settings and supported by an interactive user training program.

2BodyGuard 545
CategoryInfusion Pumps
Description

Infusion pump model in the BodyGuard product line, used for IV medication delivery in clinical settings and supported by an interactive user training program.

3T34 Syringe Pump
CategorySyringe Pumps
Description

Precision syringe pump model for controlled syringe-based medication administration, used for critical care and neonatal applications and supported by an interactive user training program.

4Disposable Administration Sets
CategoryDisposable Medical Consumables
Description

Wide range of single-use IV administration sets and medical tubing accessories used with infusion pumps for intravenous medication delivery.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Moog's medical devices segment includes infusion pumps and disposables for hospital and ambulatory use, making it a focused direct competitor in the same product category as Caesarea Medical Electronics.

TypeBroad incumbent
Description

Terumo's hospital products division includes infusion systems and syringes, competing in overlapping hospital channels with comparable IV medication delivery hardware and consumables.

TypeBroad incumbent
Description

Baxter is a global medical device leader with a large infusion systems portfolio (Sigma Spectrum, Novum) and IV solutions, competing head-to-head with Caesarea Medical Electronics across hospital infusion and syringe pump segments.

TypeBroad incumbent
Description

Fresenius Kabi produces infusion and syringe pumps (e.g., Agilia line) plus IV consumables and is a major player in the hospital infusion market, with overlapping products and a similar focus on medication delivery.

5Smiths Medical (ICU Medical)
TypeDirect peer
Description

Smiths Medical, now part of ICU Medical, manufactures syringe pumps (Graseby, Medfusion) and infusion devices — a direct competitor to Caesarea Medical Electronics in syringe-based and ambulatory infusion delivery.

TypeEmerging player
Description

Mindray is an emerging global medtech player whose patient monitoring and infusion product lines overlap with Caesarea Medical Electronics' hospital customer base, particularly in cost-sensitive and emerging markets.

TypeBroad incumbent
Description

BD acquired Caesarea Medical Electronics' former strategic investor CareFusion in 2015 and is a global leader in infusion pumps, syringe pumps, and medication delivery consumables — directly comparable to Caesarea Medical Electronics' core product portfolio and the broadest competitor in the space.

TypeBroad incumbent
Description

B. Braun manufactures infusion pumps (Infusomat, Perfusor) and disposable IV administration sets globally, with a comprehensive hospital-focused portfolio that overlaps directly with Caesarea Medical Electronics' BodyGuard and T34 offerings and consumables business.

TypeDirect peer
Description

ICU Medical is a focused specialist in IV infusion pumps, syringe pumps, and dedicated disposables — directly comparable to Caesarea Medical Electronics in product scope, target customer (hospital infusion), and business model (hardware + consumables).

10Zyno Solutions
TypeEmerging player
Description

Zyno Solutions specializes in infusion pump technology and IV delivery systems for hospitals and ambulatory settings, representing a smaller but comparable specialist peer to Caesarea Medical Electronics.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Caesarea Medical Electronics

Medical Devicescme-infusion.com

Caesarea Medical Electronics is an Israeli medical-device company founded in 1993 that designs and sells infusion pumps, syringe pumps, and disposable administration sets to hospitals, clinics, and veterinary facilities globally under the BodyGuard and T34 brands.

What Caesarea Medical Electronics does

Caesarea Medical Electronics (CME) is a privately held Israeli medical-device company founded in 1993 and headquartered in Caesarea, Israel, that designs, manufactures, and distributes infusion and syringe pumps for healthcare providers globally. Its core product portfolio centers on the BodyGuard family of infusion pumps — including the BodyGuard 323 and BodyGuard 545 multi-functional infusion therapy devices — and the T34 syringe pump, paired with a recurring stream of disposable administration sets that anchor lifetime customer value per installed device. The company operates a direct B2B go-to-market selling hardware and consumables into hospitals, clinics, and medical facilities, and has extended the same underlying platforms into a separate Vet Care channel serving veterinary clinics, providing modest vertical diversification.

CME generates revenue primarily through unit sales of regulated infusion and syringe pump hardware plus the associated disposable administration-set consumables, with supporting product training and clinical-support services that reinforce installed-base retention. The company claims global distribution and maintains an organizational headcount in the 101–250 range, consistent with a mid-sized established manufacturer rather than a growth-stage venture. Its only documented capital event in the available data is a $100M funding round led by CareFusion on 2013-12-09, which signals that a strategic acquirer/distributor once assessed material commercial scale, though no current operating, revenue, or pipeline metrics are disclosed in the input.

Technology-wise, CME is a traditional regulated-hardware medical-device manufacturer rather than a software- or AI-defined business; its website is noted to rely on Adobe Flash, indicating a dated digital footprint. The competitive positioning rests on a three-decade brand in the BodyGuard line, switching costs tied to clinical-workflow integration, and the regulatory barrier inherent in infusion-device clearances, rather than on differentiated intelligence or data capabilities.

Caesarea Medical Electronics firmographics

Firmographics
Name
Caesarea Medical Electronics
Legal name
Caesarea Medical Electronics
Website
https://cme-infusion.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
1–10 employees
Short description
Caesarea Medical Electronics is an Israeli medical-device company founded in 1993 that designs and sells infusion pumps, syringe pumps, and disposable administration sets to hospitals, clinics, and veterinary facilities globally under the BodyGuard and T34 brands.
Ownership category
akta.pro rank

Caesarea Medical Electronics industry classification

Industry
Product category
Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAIAF
Infusion Pumps (Ambulatory/Stationary)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAH
Infusion Sets, Catheters & Pump Consumables
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)

Keywords

  • Infusion pumps
  • Syringe pumps
  • IV medication delivery
  • Disposable administration sets
  • Medical device manufacturing

Where Caesarea Medical Electronics is headquartered

Location

Headquarters

HQ city
Caesarea
HQ country
Israel
HQ region
Middle East

Markets served

Caesarea Medical Electronics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

  1. Medical Device Sales: Sale of infusion pumps, syringe pumps, and related medical devices along with disposable administration sets to healthcare providers and institutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Caesarea Medical Electronics product offering

Product offering

Core offering

Caesarea Medical Electronics designs, develops, and manufactures a range of infusion and syringe pumps for intravenous (IV) medication delivery. The company produces multi-functional infusion therapy devices and a wide range of single-use disposable administration sets used in healthcare settings.

Product overview

Caesarea Medical Electronics designs and manufactures a comprehensive portfolio of intravenous medication delivery solutions. The core product line consists of infusion pumps and syringe pumps for controlled IV medication administration, complemented by multi-functional infusion therapy devices. The company also produces disposable administration sets as consumable accessories. Specific product models referenced include the BodyGuard 323, BodyGuard 545 infusion pumps, and T34 Syringe Pump. The portfolio targets healthcare providers requiring reliable IV medication delivery and infusion therapy capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • BodyGuard 323 Infusion pump model in the BodyGuard product line, used for intravenous medication delivery in clinical settings and supported by an interactive user training program.
  • BodyGuard 545 Infusion pump model in the BodyGuard product line, used for IV medication delivery in clinical settings and supported by an interactive user training program.
  • T34 Syringe Pump Precision syringe pump model for controlled syringe-based medication administration, used for critical care and neonatal applications and supported by an interactive user training program.
  • Disposable Administration Sets Wide range of single-use IV administration sets and medical tubing accessories used with infusion pumps for intravenous medication delivery.

Companies that use Caesarea Medical Electronics

Customer profile

Segments1 record

Ideal customer profiles1 record

Caesarea Medical Electronics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Caesarea Medical Electronics partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Caesarea Medical Electronics competitors and assessment

Company assessment

Direct peers

  • Moog Inc. Moog's medical devices segment includes infusion pumps and disposables for hospital and ambulatory use, making it a focused direct competitor in the same product category as Caesarea Medical Electronics.
  • Smiths Medical (ICU Medical): Smiths Medical, now part of ICU Medical, manufactures syringe pumps (Graseby, Medfusion) and infusion devices — a direct competitor to Caesarea Medical Electronics in syringe-based and ambulatory infusion delivery.
  • ICU Medical: ICU Medical is a focused specialist in IV infusion pumps, syringe pumps, and dedicated disposables — directly comparable to Caesarea Medical Electronics in product scope, target customer (hospital infusion), and business model (hardware + consumables).

Broad incumbents

  • Terumo: Terumo's hospital products division includes infusion systems and syringes, competing in overlapping hospital channels with comparable IV medication delivery hardware and consumables.
  • Baxter International: Baxter is a global medical device leader with a large infusion systems portfolio (Sigma Spectrum, Novum) and IV solutions, competing head-to-head with Caesarea Medical Electronics across hospital infusion and syringe pump segments.
  • Fresenius Kabi: Fresenius Kabi produces infusion and syringe pumps (e.g., Agilia line) plus IV consumables and is a major player in the hospital infusion market, with overlapping products and a similar focus on medication delivery.
  • Becton, Dickinson and Company (BD): BD acquired Caesarea Medical Electronics' former strategic investor CareFusion in 2015 and is a global leader in infusion pumps, syringe pumps, and medication delivery consumables — directly comparable to Caesarea Medical Electronics' core product portfolio and the broadest competitor in the space.
  • B. Braun: B. Braun manufactures infusion pumps (Infusomat, Perfusor) and disposable IV administration sets globally, with a comprehensive hospital-focused portfolio that overlaps directly with Caesarea Medical Electronics' BodyGuard and T34 offerings and consumables business.

Emerging players

  • Mindray: Mindray is an emerging global medtech player whose patient monitoring and infusion product lines overlap with Caesarea Medical Electronics' hospital customer base, particularly in cost-sensitive and emerging markets.
  • Zyno Solutions: Zyno Solutions specializes in infusion pump technology and IV delivery systems for hospitals and ambulatory settings, representing a smaller but comparable specialist peer to Caesarea Medical Electronics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Caesarea Medical Electronics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Caesarea Medical Electronics leadership team

Management profile

Number of profiles

Caesarea Medical Electronics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Caesarea Medical Electronics M&A and investment

M&A and investment

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caesarea Medical Electronics

What does Caesarea Medical Electronics do?

Caesarea Medical Electronics designs, develops, and manufactures a range of infusion and syringe pumps for intravenous (IV) medication delivery. The company produces multi-functional infusion therapy devices and a wide range of single-use disposable administration sets used in healthcare settings.

When was Caesarea Medical Electronics founded?

Caesarea Medical Electronics was founded in 1993. It employs 1 to 10 people.

Where is Caesarea Medical Electronics based?

Caesarea Medical Electronics is headquartered in Caesarea, Israel, in the Middle East region.

How does Caesarea Medical Electronics make money?

One revenue line is on record: medical Device Sales.

Who are Caesarea Medical Electronics's main competitors?

Direct peers on record are Moog Inc., Smiths Medical (ICU Medical) and ICU Medical. Broad incumbents are Terumo, Baxter International, Fresenius Kabi, Becton, Dickinson and Company (BD) and B. Braun. Emerging players are Mindray and Zyno Solutions.

Does Caesarea Medical Electronics have an API?

No public API is recorded for Caesarea Medical Electronics.

What industry is Caesarea Medical Electronics in?

Caesarea Medical Electronics's product category is Medical Devices. Its primary akta.pro industry code is HLAHAIAF, Infusion Pumps (Ambulatory/Stationary), with a secondary code of HLAHAIAH, Infusion Sets, Catheters & Pump Consumables. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlobal Home Infusion Therapy Market Report 2020-2025 Featuring Braun, CareFusion, ICU Medical, Baxter, Smith's Medical, Caesarea Medical Electronics, Terumo, JMS, Hospira, and Abbott LaboratoriesResearch and Markets has published a report forecasting the global home infusion therapy market to reach USD 30.4 billion by 2025, growing at a CAGR of 8.9% from 2020. The study identifies key growth drivers such as an aging population and technological advancements, while noting the Asia Pacific region as a rapidly expanding market. It profiles major industry players including Baxter, ICU Medical, and Abbott Laboratories.PR NewswireWorldwide Home Infusion Therapy Industry to 2025 - Key Mergers and AcquisitionsResearchAndMarkets.com published a market research report on the global home infusion therapy industry, projecting the market to grow from USD 18.11 billion in 2020 to USD 30.4 billion by 2025, representing a compound annual growth rate of 8.9%. The report identifies key growth drivers including the rising elderly population, advancements in healthcare technology enabling easier home use, and increased demand driven by the COVID-19 pandemic restricting hospital visits. Key players analyzed in the report include B. Braun Melsungen AG, CareFusion Corporation, ICU Medical Inc., Baxter Inc, Smith's Medical, Caesarea Medical Electronics, Terumo Corporation, JMS Co. Ltd, Hospira Inc, and Abbott Laboratories.PR NewswireHome Infusion Therapy Market to Cross $41 Billion by 2027 - Key Players are B. Braun Melsungen, Baxter, Caesarea Medical Electronics, CareFusion Corp, and Fresenius Kabi, Amongst OthersA market research report forecasts that the global home infusion therapy market will reach USD 41.6 billion by 2027, driven by rising chronic disease prevalence and favorable government regulations such as the Bipartisan Budget Act of 2018 in the United States. Key growth factors include technological advancements in infusion devices and increased coverage for home-based treatments as an alternative to hospital stays.GlobeNewswireHospital-Acquired Infection Diagnostics Market to Reach $4,386.6 Million by 2023: P&S Market ResearchP&S Market Research forecasts the hospital-acquired infection diagnostics market to reach $4,386.6 million by 2023, growing at a 7.6% CAGR. The immunoassay segment led with $1,195.0 million in 2016, and reagents and consumables held a 63.1% product share. Abbott's planned acquisition of Alere and Becton Dickinson's acquisition of Caesarea Medical Electronics were also noted.Mpo-magBD Completes Acquisition of Caesarea Medical ElectronicsBD completed the acquisition of Israeli-based Caesarea Medical Electronics, a global infusion pump manufacturer. The deal expands BD's infusion portfolio to include ambulatory, home, and specialty acute care pumps. The transaction completes the remaining 60% stake after CareFusion acquired a 40% stake in 2014.